Paper Title International Pharma Congresses during Covid-19

November 2020Management Pharmaceutical

Abstract

Pharmaceutical congresses and conferences are one of the preferred resources for doctors to learn about new research, treatments and indications . Such congresses in 2020 have become ‘virtual’ in response to the Covid-19 pandemic. Normally, the content and events at a physical international congress are designed to comply with the host country’s laws and regulations on the promotion of pharmaceutical products . In the event of a virtual, fully digital congress, it may not be so obvious which country is the host country from a legal & regulatory perspective. Pharmaceutical companies participating in international congresses must therefore assess the question of jurisdiction and applicable laws to proactively comply, and reactively, if required, to go through administrative and/or litigious proceedings eventually brought by health authorities or competitors alike.

Subscribe to reador

Managing risk can be complicated in the best of times, and the challenges associated with risk management become even greater when combined with the tremendous disruption caused by a global...Read more

Fabiana Lacerca-Allen

Chief Compliance Officer, Cipla, USA

Tatiyana Akers

Associate Director, Compliance, Aimmune Therapeutics, USA

Laura Hamm

Sr. Director, Corporate Compliance, Aimmune Therapeutics, USA

Brenda Crabtree

Director, Compliance Auditing and Monitoring, Aimmune Therapeutics, USA

Making it Stick: How to Provide Legal Advice that Influences Business Decisions

As attorneys, determining the most risk-averse legal advice to give to our business partners often comes naturally. After all, we have both academic and professional experience in considering legal questions. But...

Paper Title International Pharma Congresses during Covid-19

Abstract

Related Papers